Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 5 1:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John L. who wrote (1066)	7/22/1998 1:40:00 AM
From: Todd D. Wiener	Read Replies (1) of 1432

John- Just a small item: If BTIM is getting top line of $144 million, figure no more than a 60% bottom line number, due to SG&A, increased R&D, and a tax rate of 35% (since the NOL will be used up very quickly with such strong income). That leaves $85 million in net income, with possibly 11 million shares in 3 years, that's $7.75 per share. If this were possible, it would be a tremendous accomplishment. But BTIM needs to be able to fully penetrate this market, via Abbott. And this doesn't consider the potential for pricing issues ($100 may be too high?). Todd

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next